CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: Delineation of consensus motif in the V3 domain that predicts CCR-5 usage

Virology

Volumn 240, Issue 1, 1998, Pages 83-92

  Xiao, Lihua ^a   Owen, Sherry M ^a   Goldman, Ira ^a   Lal, Altaf A ^a   Dejong, Jacques J ^b   Goudsmit, Jaap ^b   Lal, Renu B ^a  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR;

ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MONONUCLEAR CELL; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; SYNCYTIUM; T LYMPHOCYTE;

EID: 0032484486     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8924     Document Type: Article

References (42)

1. Alkhatib G., Combadiere C., Broder C. C., Feng Y., Kennedy P. E., Murphy P. M., Berger E. A. CC CKR5: A RANTES, MIP-1α, and MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1996;1955-1958.
2. Atchison R., Gosling E. J., Monteclaro F. S., Franci C., Digilio L., Charo I. F., Goldsmith M. A. Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from responses to chemokines. Science. 274:1996;1924-1927.
3. Bhattacharya D., Brooks B. R., Callahan L. Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype. AIDS Res. Hum. Retroviruses. 12:1996;83-91.
4. Cheng-Mayer C., Liu R., Landau N. R., Stamatatos L. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor. J. Virol. 71:1997;1657-1661.
5. Chesebro B., Wehrly K., Nishio J., Perryman S. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism. J. Virol. 66:1992;6547-6554.
6. Chesebro B., Werley K., Nishio J., Perryman S. mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. J. Virol. 70:1996;9055-9059.
7. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P. D., Wu L., Mackay C. R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1996;1135-1148.
8. Cocchi F., DeVico A. L., Garzino-Demo L., Arya S. K., Gallo R. C., Lusso P. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science. 270:1996a;1811-1815.
9. Cocchi F., DeVico A. L., Garzino-Demo L., Cara A., Gallo R. C., Lusso P. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nature Med. 2:1996b;1244-1247.
10. Connor R. I., Ho D. D. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68:1994;4400-4408.
11. Connor R. I., Paxton W. A., Sheridan K. E., Koup R. A. Macrophage and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1. J. Virol. 70:1996;8758-8764.
12. deJong J-J., Ronde A. D., Keulen W., Tersmette M., Goudsmit J. Minimal requirement for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: Analysis by single amino acid substitution. J. Virol. 66:1992a;6777-6780.
13. deJong J-J., Goudsmit J., Keulen W., Klaver B., Krone W., Tersmette M., deRonde A. Human immunodeficiency virus type 1 clones chimeric for the envelop V3 domain differ in syncytium formation and replication capacity. J. Virol. 66:1992b;757-765.
14. Deng D., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., DiMarzio P., Marmon S., Sutton R. E., Hill C. M. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-665.
15. Dittmar M. T., McKnight A., Simmons G., Clapham P. R., Weiss R. A., Simmonds P. HIV-1 tropism and coreceptor use. Nature. 385:1997;496-497.
16. Doranz B. J., Rucker J., Yi Y., Smith R. J., Samson M., Peiper S. C., Parmentier M., Collman R. G., Doms R. W. A dual-tropic primary HIV-1 isolate that uses Fusin and the β-chemokine receptor CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1996;1149-1158.
17. Dragic T., Litwin V., Allaway G. P., Martin S. R., Huang Y., Nagashima K. A., Cayanan C., Maddon P. J., Koup R. A., Moore J. P., Paxton W. A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
18. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science. 272:1996;872-877.
19. Fouchier R. A., Groenink M., Kootstra N. A., Tersmette M., Huisman H. G., Miedema F., Schuitemaker H. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66:1992;3183-3187.
20. Gao F., Morrison S. G., Robertson D. L., Thornton C. L., Craig S., Karlsson G., Sodroski J., Morgado M., Castro B. G., Briesen H., Beddows S., Weber J., Sharp P. M., Shaw G., Hahn B. H. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. J. Virol. 70:1996;1651-1667.
21. Hwang S. S., Boyle T. J., Lyerly H. K., Cullen B. R. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science. 253:1991;71-74.
22. Kabat D., Kozak S. L., Wehrly K., Chesebro B. Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J. Virol. 68:1994;2570-2577.
23. Kozak S. L., Platt E. J., Madani N., Ferro F. E. Jr., Peden K., Kabat D. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J. Virol. 71:1997;873-882.
24. Kuiken C. L., deJong J. J., Baan E., Keulen W., Tersmette M., Goudsmit J. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J. Virol. 66:1992;4622-4627.
25. Liu R., Paxton W. A., Choe S., Ceradini D., Martin S. R., Horuk R., McDonald M. E., Stuhlmann H., Koup R. A., Landau N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
26. McKnight A., Wilkinson D., Simmons G., Talbot S., Picard L., Ahuja M., Marsh M., Hoxie J. A., Clapham P. R. Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J. Virol. 71:1997;1692-1696.
27. Moore J. P., Cao Y., Qing L., Sattentau Q. J., Pyati J., Koduri R., Robinson R., Barbas C. F., Burton D. R., Ho D. D. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69:1995;101-109.
28. Paxton W. A., Martin S. R., Tse D., O'Brien T. R., Skurnick J., vanDevanter N. L., Padian N., Braun J. F., Kotler D. P., Wolinsky S. M., Koup R. A. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med. 2:1996;412-417.
29. Roos M. T., Lange J. M., deGoede R. E., Coutinho R. A., Schellekens P. T., Miedema F., Tersmette M. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J. Infect. Dis. 165:1992;427-432.
30. Rucker J., Samson M., Doranz B. J., Libert F., Berson J. F., Yi Y., Smyth R. J., Collman R. G., Broader C. C., Vassart G., Doms R. W., Parmentier M. Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell. 87:1996;437-446.
31. Schuitemaker H., Kootstra N. A., Goede R. D., Wolf F. D., Miedema F., Mersmette M. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J. Virol. 65:1991;356-363.
32. Schuitemaker H., Koot M., Kootstra N. A., Dercksen M. W., deGoede R. E., van Steenwijk R. P., Lange J. M., Schattenkerk J. K., Miedema F. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66:1992;1354-1360.
33. Shioda T., Ley J. A., Cheng-Mayer C. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature. 349:1991;167-169.
34. Shioda T., Ley J. A., Cheng-Mayer C. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 89:1992;9434-9438.
35. Simmons G., Wilkinson D., Reeves J. D., Dittmar M. T., Beddows S., Weber J., Carnegie G., Desselberger U., Gray P. W., Weiss R. A., Clapham P. R. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70:1996;8355-8360.
36. Speck R. F., Wehrly K., Platt E. J., Atchison R. E., Charo I. F., Kabat D., Chesebro B., Goldsmith M. A. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individuals amino acids within the envelope V3 loop. J. Virol. 71:1997;7136-7139.
37. Trkola A., Dragic T., Arthos J., Binley J. M., Olson W. C., Allaway G. P., Cheng-Mayer C., Robinson J., Maddon P. J., Moore J. P. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature. 384:1996;184-188.
38. Valentin A., Albert J., Fenyo M., Asjo M. Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J. Virol. 68:1994;6684-6689.
39. Weiss R. A., Clapham P. R. AIDS: hot fusion of HIV. Nature. 381:1996;647-648.
40. Wu L., Gerard N. P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A. A., Desjardin E., Newman W., Gerard C., Sodroski J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature. 384:1996;179-184.
41. Zhang L., Huang Y., He T., Cao Y., Ho D. D. HIV-1 subtype and second receptor use. Nature. 383:1996.
42. Zhu T., Mo H., Wang N., Nam D. S., Cao Y., Koup R. A., Ho D. D. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science. 261:1993;1179-1181.